DNA Nanostructures-Based Delivery System for Cancer Immunotherapy Shows Promising Results

Researchers from Fudan University have explored the use of DNA nanostructures-based materials to improve the therapeutic efficacy of cancer immunotherapy. The study aims to address the challenges of low drug loading, imprecise targeting, and non-specific releasing in current cancer treatments. The researchers designed a DNA nanostructure-based delivery system that can achieve high loading capability, precise targeting, and controllable releasing of immunotherapeutics. Their research concludes that this approach has the potential to improve therapeutic efficacy and reduce side effects in cancer treatment.

Key Takeaways:

• The study highlights the challenges of current cancer treatments, including low drug loading, imprecise targeting, and non-specific releasing.
• DNA nanostructures-based materials have been explored to improve therapeutic efficacy and reduce side effects in cancer treatment.
• The researchers designed a DNA nanostructure-based delivery system that can achieve high loading capability, precise targeting, and controllable releasing of immunotherapeutics.
• The study discusses the use of nucleic acid aptamers to enhance precise targeting ability and enable immune checkpoint inhibitions.
• The researchers present recent progress on the controllable release of immunotherapeutics triggered by specific stimuli.
• The study provides insights for the subsequent realization of applications of DNA nanostructures-based materials for cancer immunotherapy in the future.
• The researchers involved in the study are Dayong Yang, Rui Zhang, and Tailing Xue from Fudan University.
• The research has been supported by the National Natural Science Foundation of China (NSFC) and Fudan University Ruiqing Education.
• The study highlights the potential of DNA nanostructures-based materials in improving cancer treatment.

Statistics:

• The study focuses on cancer immunotherapy, which has been emerging as a potent strategy for cancer treatment.
• The researchers explored DNA nanostructures-based materials, which have been shown to achieve high loading capability, precise targeting, and controllable releasing.
• The study discusses the use of nucleic acid aptamers to enhance precise targeting ability, with a specific mention of enabling immune checkpoint inhibitions.
• The researchers present recent progress on the controllable release of immunotherapeutics, with a specific mention of the use of specific stimuli.
• The study provides insights for the subsequent realization of applications of DNA nanostructures-based materials for cancer immunotherapy in the future.

Sources:

• NewsRx. Researchers from Fudan University Detail New Studies and Findings in the Area of Cancer (Dna Nanostructures-based Delivery System for Cancer Immunotherapy). Immunotherapy Weekly. August 6, 2025; p 3473.
• Dna Nanostructures-based Delivery System for Cancer Immunotherapy. Nano Research, 2025;18(7).